# CVS Health vs Regeneron Pharmaceuticals: stocks compared

URL: https://funkfolio.com/compare/cvs-vs-regn

> CVS Health ($109.8B, P/E 10.0) and Regeneron Pharmaceuticals ($99.1B, P/E 21.2) compared: size, valuation, margins, debt, cash and price change.

---

## CVS Health vs Regeneron Pharmaceuticals

CVS Health (CVS), health care, and Regeneron Pharmaceuticals (REGN), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.

CVS Health is worth $109.8B on the stock market and Regeneron Pharmaceuticals $99.1B: CVS Health is valued at 11% more. CVS Health trades at 10.0 times earnings and Regeneron Pharmaceuticals at 21.2; operating margins in their latest fiscal years were 1.16% and 24.9%. Over the past year CVS Health's share price has moved +13.7% and Regeneron Pharmaceuticals's +31.3%.

### Key facts

- **CVS Health market value:** $109.8B
- **Regeneron Pharmaceuticals market value:** $99.1B
- **CVS Health P/E:** 10.0
- **Regeneron Pharmaceuticals P/E:** 21.2
- **CVS Health revenue:** $402.1B FY to 2025-12-31
- **Regeneron Pharmaceuticals revenue:** $14.3B FY to 2025-12-31
- **Superinvestors holding both:** 5

Market values as of 18 Nov 2026, 00:08 UTC.

CVS Health vs Regeneron Pharmaceuticals: every measure side by side

| Measure | CVS Health | Regeneron Pharmaceuticals |
| --- | --- | --- |
| Sector | Health Care | Health Care |
| Country | United States | United States |
| Fiscal year ends | 2025-12-31 | 2025-12-31 |
| Size |  |  |
| Market cap | $109.8B higher | $99.1B lower |
| Revenue | $402.1B higher | $14.3B lower |
| Earnings | $1.8B lower | $4.5B higher |
| Employees | 219,000 higher | 15,410 lower |
| Total assets | $253.5B higher | $40.6B lower |
| Valuation |  |  |
| P/E | 10.0 lower | 21.2 higher |
| P/S | 0.3 lower | 6.9 higher |
| P/B | 1.4 lower | 2.9 higher |
| Dividend yield | 3.00% higher | 0.39% lower |
| Profitability |  |  |
| Operating margin | 1.16% lower | 24.9% higher |
| Balance sheet |  |  |
| Net assets | $75.2B higher | $31.3B lower |
| Total liabilities | $178.2B higher | $9.3B lower |
| Total debt | $64.6B higher | $2B lower |
| Cash on hand | $8.5B higher | $3.1B lower |
| Price change |  |  |
| Today | -3.14% lower | +0.56% higher |
| 1 year | +13.7% lower | +31.3% higher |

Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.

### Share price over one year

Each company's share price rebased to 100 on Nov 17, 2025, so the two lines start together. Price only: dividends are not included. Last: CVS Health 109.4, Regeneron Pharmaceuticals 136.0.

- CVS Health (CVS)
- Regeneron Pharmaceuticals (REGN)

CVS Health and Regeneron Pharmaceuticals share prices over one year, rebased to 100: CVS Health ends at 109.4, Regeneron Pharmaceuticals at 136.0.

**The chart as a table**

Month-end share prices rebased to 100

| Month end | CVS | REGN |
| --- | --- | --- |
| Nov 28, 2025 | 102.5 | 110.8 |
| Dec 31, 2025 | 101.2 | 109.6 |
| Jan 30, 2026 | 95.0 | 105.3 |
| Feb 27, 2026 | 101.9 | 111.0 |
| Mar 31, 2026 | 91.6 | 109.7 |
| Apr 30, 2026 | 106.2 | 100.4 |
| May 29, 2026 | 116.0 | 87.3 |
| Jun 30, 2026 | 131.9 | 88.5 |
| Jul 31, 2026 | 133.2 | 108.3 |
| Aug 31, 2026 | 119.8 | 113.5 |
| Sep 30, 2026 | 109.3 | 107.7 |
| Oct 30, 2026 | 115.1 | 131.7 |
| Nov 17, 2026 | 109.4 | 136.0 |

### Which superinvestors hold them

From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.

#### Both (5)

- [Dodge & Cox team](https://funkfolio.com/gurus/dodge-and-cox) 2.1% / 1.9%
- [Josef Lakonishok](https://funkfolio.com/gurus/josef-lakonishok) 0.7% / 0.3%
- [Jim Simons (1938–2024)](https://funkfolio.com/gurus/jim-simons) 0.3% / 0.3%
- [Ray Dalio (founder)](https://funkfolio.com/gurus/bridgewater) 0.2% / 0.1%
- [Jeremy Grantham (co-founder)](https://funkfolio.com/gurus/jeremy-grantham) 0.1% / 0.1%

#### CVS Health only (17)

- [Larry Robbins](https://funkfolio.com/gurus/larry-robbins) 10.0%
- [Prem Watsa](https://funkfolio.com/gurus/prem-watsa) 8.8%
- [Christopher Davis](https://funkfolio.com/gurus/christopher-davis) 4.4%
- [Samantha McLemore](https://funkfolio.com/gurus/samantha-mclemore) 2.8%
- [Richard Pzena](https://funkfolio.com/gurus/richard-pzena) 2.6%
- [Andreas Halvorsen](https://funkfolio.com/gurus/andreas-halvorsen) 1.1%
- [Charles Brandes (founder)](https://funkfolio.com/gurus/charles-brandes) 0.9%
- [Mark Boyar](https://funkfolio.com/gurus/mark-boyar) 0.8%
- [John Rogers](https://funkfolio.com/gurus/john-rogers) 0.7%
- [Brandon Haley](https://funkfolio.com/gurus/brandon-haley) 0.7%
- [Rajiv Jain](https://funkfolio.com/gurus/rajiv-jain) 0.5%
- [Steve Cohen](https://funkfolio.com/gurus/steve-cohen) 0.3%
- [Ken Griffin](https://funkfolio.com/gurus/ken-griffin) 0.3%
- [Paul Tudor Jones](https://funkfolio.com/gurus/paul-tudor-jones) 0.2%
- [Israel Englander](https://funkfolio.com/gurus/israel-englander) 0.2%
- [Primecap team](https://funkfolio.com/gurus/primecap) 0.1%
- [Bill Nygren](https://funkfolio.com/gurus/bill-nygren) &lt;0.1%

#### Regeneron Pharmaceuticals only (5)

- [Mason Hawkins](https://funkfolio.com/gurus/mason-hawkins) 5.0%
- [Harry Burn](https://funkfolio.com/gurus/harry-burn) 3.0%
- [John Overdeck and David Siegel (founders)](https://funkfolio.com/gurus/two-sigma) 0.5%
- [Cliff Asness](https://funkfolio.com/gurus/cliff-asness) 0.2%
- [Joel Greenblatt](https://funkfolio.com/gurus/joel-greenblatt) 0.2%

Percentages are each holding's share of that investor's reported portfolio (under "Both": CVS Health / Regeneron Pharmaceuticals). [Who owns CVS](https://funkfolio.com/stock/CVS/superinvestors) · [Who owns REGN](https://funkfolio.com/stock/REGN/superinvestors)

### More on CVS Health

- [CVS Health (CVS) stock page](https://funkfolio.com/stock/CVS)
- [CVS Health market cap](https://funkfolio.com/stock/CVS/market-cap)
- [CVS Health revenue](https://funkfolio.com/stock/CVS/revenue)
- [CVS Health P/E ratio](https://funkfolio.com/stock/CVS/pe-ratio)
- [CVS Health operating margin](https://funkfolio.com/stock/CVS/operating-margin)
- [CVS Health total debt](https://funkfolio.com/stock/CVS/total-debt)
- [Largest health care companies](https://funkfolio.com/companies/sector/health-care)

### More on Regeneron Pharmaceuticals

- [Regeneron Pharmaceuticals (REGN) stock page](https://funkfolio.com/stock/REGN)
- [Regeneron Pharmaceuticals market cap](https://funkfolio.com/stock/REGN/market-cap)
- [Regeneron Pharmaceuticals revenue](https://funkfolio.com/stock/REGN/revenue)
- [Regeneron Pharmaceuticals P/E ratio](https://funkfolio.com/stock/REGN/pe-ratio)
- [Regeneron Pharmaceuticals operating margin](https://funkfolio.com/stock/REGN/operating-margin)
- [Regeneron Pharmaceuticals total debt](https://funkfolio.com/stock/REGN/total-debt)
- [Largest health care companies](https://funkfolio.com/companies/sector/health-care)

### Further comparisons

#### CVS Health against its closest peers

- [CVS Health vs Moderna](https://funkfolio.com/compare/cvs-vs-mrna)
- [CVS Health vs HCA Healthcare](https://funkfolio.com/compare/cvs-vs-hca)
- [CVS Health vs GSK](https://funkfolio.com/compare/cvs-vs-gsk)
- [CVS Health vs Sanofi](https://funkfolio.com/compare/cvs-vs-sny)

#### Regeneron Pharmaceuticals against its closest peers

- [Regeneron Pharmaceuticals vs Elevance Health](https://funkfolio.com/compare/elv-vs-regn)
- [Regeneron Pharmaceuticals vs GSK](https://funkfolio.com/compare/gsk-vs-regn)
- [Regeneron Pharmaceuticals vs HCA Healthcare](https://funkfolio.com/compare/hca-vs-regn)

### Learn

- [What market capitalization is and is not](https://funkfolio.com/learn/markets/market-capitalization)
- [P/E ratio explained](https://funkfolio.com/learn/stocks/pe-ratio)
- [Market cap vs enterprise value](https://funkfolio.com/learn/markets/market-cap-vs-enterprise-value)

### Questions and answers

**Which is bigger, CVS Health or Regeneron Pharmaceuticals?**

By market value, CVS Health is the larger: $109.8B against $99.1B for Regeneron Pharmaceuticals. By revenue in its latest fiscal year, CVS Health is the larger: $402.1B against $14.3B for Regeneron Pharmaceuticals.

**Which has the higher P/E ratio?**

Regeneron Pharmaceuticals: 21.2, against 10.0 for CVS Health. A higher P/E means the market pays more for each dollar of the last twelve months' earnings; on its own it does not say which is the better value.

**Which has the higher operating margin?**

Regeneron Pharmaceuticals: 24.9%, against 1.16% for CVS Health. Operating margin is operating income as a share of revenue in the latest fiscal year.

**Which has the higher dividend yield?**

CVS Health: 3.00%, against 0.39% for Regeneron Pharmaceuticals. Dividend yield is the last twelve months' dividends as a share of today's share price.

**Which has more debt?**

CVS Health: $64.6B, against $2B for Regeneron Pharmaceuticals. Total debt is borrowings at the end of the latest fiscal year, as each company reported it; it is not set against cash here.

**Which superinvestors own both CVS Health and Regeneron Pharmaceuticals?**

In their latest 13F filings, Dodge & Cox team, Josef Lakonishok, Jim Simons (1938–2024), Ray Dalio (founder) and Jeremy Grantham (co-founder) hold both.

### Cite this page

Funkfolio, “CVS Health vs Regeneron Pharmaceuticals”, data as of 18 November 2026. https://funkfolio.com/compare/cvs-vs-regn

Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.
